TY  - JOUR
AU  - Machuca, Isabel
AU  - Gutierrez-Gutierrez, Belen
AU  - Gracia-Ahufinger, Irene
AU  - Rivera Espinar, Francisco
AU  - Cano, Angela
AU  - Guzman-Puche, Julia
AU  - Perez-Nadales, Elena
AU  - Natera, Clara
AU  - Rodriguez, Marina
AU  - Leon, Rafael
AU  - Caston, Juan J.
AU  - Rodriguez-Lopez, Fernando
AU  - Rodriguez-Bano, Jesus
AU  - Torre-Cisneros, Julian
PY  - 2017
DO  - 10.1128/AAC.00406-17
SN  - 0066-4804
UR  - http://hdl.handle.net/10668/18999
T2  - Antimicrobial agents and chemotherapy
AB  - Combination therapy including colistin and a carbapenem has been found to be associated with lower mortality in the treatment of bloodstream infections (BSI) due to KPC-producing Klebsiella pneumoniae when the isolates show a meropenem or imipenem MIC...
LA  - en
PB  - American Society for Microbiology
KW  - Klebsiella pneumoniae
KW  - Bacteremia
KW  - Carbapenems
KW  - Colistin
KW  - Mortality
KW  - Blood-stream infections
KW  - K.-pneumoniae
KW  - Enterobacteriaceae
KW  - Gentamicin
KW  - Predictors
KW  - Outcomes
KW  - Sepsis
KW  - Impact
KW  - Definitions
KW  - Emergence
KW  - Colistin
KW  - Meropenem
KW  - Klebsiella pneumoniae
KW  - Shock, septic
KW  - Confidence intervals
KW  - Propensity score
KW  - Regression analysis
KW  - Critical care
TI  - Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems
TY  - Research article
VL  - 61
ER  -